新闻中心

2017.10.10
Mutational landscape of cfDNA identifies distinct molecular features associated with therapeutic response to first-line platinum based doublet chemotherapy in patients with advanced NSCLC. Theranostics. 2017; 7(19): 4753-4762

  返    回